- Country: Czech Republic
- Summary: Antidiabetika Xiii. - Forxiga, Xigduo
- CZT Ref No: 124262811
- Deadline: 09 Sep 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CZK 74659000
- Notice Type: Tender
- Document Ref. No.: 523451-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The subject of the public contract is the supply of medicinal products containing the active substances dapagliflozin and a combination of dapagliflozin/metformin (ATC A10BK01 and A10BD15) for the treatment of patients in approved indications according to SPC valid as of the offer of tenders.
- FORXIGA, XIGDUO
DOC TITLE: Antidiabetics XIII. Forxiga, Xigduo
Contract Type: supplies - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAntidiabetika Xiii. - Forxiga, Xigduo - Czech Republic Tender
The INSTITUTE OF CLINICAL AND EXPERIMENTAL MEDICINE, a Government sector organization in Czech Republic, has announced a new tender for Antidiabetika Xiii. - Forxiga, Xigduo. This tender is published on CzechRepublicTenders under CZT Ref No: 124262811 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-09.
The estimated tender value is CZK 74659000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
